You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Drugs Containing Excipient (Inactive Ingredient) SUCRALOSE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing SUCRALOSE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing SUCRALOSE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Sucralose

Introduction to Sucralose

Sucralose, a high-intensity sweetener, is approximately 600 times sweeter than sugar but contains zero calories. Its versatility extends beyond food and beverages, making it a significant player in the pharmaceutical industry.

Global Market Size and Growth

The global sucralose market is projected to grow from USD 3.73 billion in 2023 to USD 6.25 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.3%[1].

Key Drivers of Market Growth

Growing Awareness of Oral Health

The increasing awareness regarding oral health and the non-cariogenic characteristics of sucralose make it a desirable sweetener for oral care products, contributing to market growth[1].

Pharmaceutical Applications

Sucralose is widely used in the pharmaceutical industry to enhance the palatability of medications, particularly those with bitter tastes. This is crucial for patient compliance, especially in pediatric and geriatric formulations[3].

Globalization and Urbanization

Globalization and urbanization, particularly in emerging economies, provide lucrative growth opportunities for the sucralose market. These trends lead to increased demand for processed and fortified foods, as well as pharmaceutical products[1].

Market Segments and Growth Rates

Form Segments

The liquid form segment of sucralose is expected to grow at the highest CAGR during the forecast period. Liquid sucralose is ideal for aqueous-based foods, beverages, and pharmaceutical products due to its ease of mixing and stability[1].

Application Segments

The pharmaceutical segment is anticipated to grow at the highest CAGR. Sucralose's effectiveness in masking bitterness and improving patient compliance makes it a vital ingredient in various pharmaceutical applications, including OTC medications, prescription drugs, and dietary supplements[1].

Regional Market Dynamics

North America

North America is expected to grow at the highest CAGR within the global sucralose market. This growth is attributed to extensive consumer acceptance, particularly in the United States, and a robust regulatory framework overseeing food additives and sweeteners[1].

Asia-Pacific

The Asia-Pacific region is also expected to see significant growth due to its expanding pharmaceutical industry and favorable healthcare policies. Countries like China, India, and Korea are driving this growth with their low manufacturing costs and supportive government policies[5].

Market Restraints

Availability of Substitutes

The presence of natural alternatives such as stevia and monk fruit may restrict sucralose's market prospects in some product categories or segments of the population. These alternatives are gaining popularity, especially among health-conscious consumers[1].

Opportunities in the Market

Compound Use with Other Sweeteners

The trend of using compound sweeteners, such as combining sucralose with erythritol, is becoming notable in the downstream food and beverage industry. This combination provides a taste closer to sucrose, improving product stability and shelf-life[4].

New Biosynthetic Technologies

While sucralose is currently produced mainly through chemical synthesis, the emergence of new biosynthetic technologies could offer more efficient and sustainable production methods, potentially expanding the market further[4].

Financial Performance of Key Players

Major players in the sucralose market include Tate and Lyle, JK Sucralose Inc., LAndP Food Ingredient Co. Ltd., Newtrend Group, BioPlus Life Sciences, and Ingredion Incorporated. These companies are investing heavily in research and development to enhance their market positions and expand their product portfolios[1][2].

Recent Developments

In July 2021, KPS Capital Partners purchased a share in Tate and Lyle for USD 1.3 billion, forming NewCo, which will focus on producing plant-based goods for the food and industrial sectors. This move indicates a strategic shift towards more sustainable and diverse product offerings[1].

Pharmaceutical Applications and Benefits

Sucralose is highly valued in pharmaceutical applications due to its ability to mask bitterness and medicinal off-notes, improving patient compliance. It is readily soluble, stable in aqueous and heat conditions, and compliant with various pharmaceutical standards (Ph. Eur., JPE, and USP-NF)[3].

Taste and Palatability

The taste and palatability of oral formulations are critical, especially for pediatric and geriatric patients. Sucralose's clean, sugar-like taste and its ability to enhance the palatability of medications make it an essential ingredient in these formulations[3].

Conclusion

The sucralose market is poised for significant growth driven by its versatility, particularly in the pharmaceutical sector. The increasing demand for better-tasting medications, the expansion of its application scope, and the emergence of new production technologies are key factors driving this growth.

Key Takeaways

  • The global sucralose market is projected to reach USD 6.25 billion by 2033.
  • The pharmaceutical segment is expected to grow at the highest CAGR.
  • North America and the Asia-Pacific region are key growth areas.
  • Liquid form sucralose is anticipated to grow at the highest CAGR.
  • The availability of natural substitutes is a market restraint.
  • Compound use with other sweeteners and new biosynthetic technologies offer growth opportunities.

FAQs

What is the projected growth rate of the global sucralose market?

The global sucralose market is expected to grow at a CAGR of 5.3% from 2023 to 2033[1].

Which segment is expected to grow at the highest CAGR in the sucralose market?

The pharmaceutical segment is anticipated to grow at the highest CAGR during the forecast period[1].

What are the key benefits of sucralose in pharmaceutical applications?

Sucralose enhances the palatability of medications, masks bitterness and medicinal off-notes, and is stable in aqueous and heat conditions, making it ideal for pharmaceutical use[3].

Which regions are expected to drive the growth of the sucralose market?

North America and the Asia-Pacific region are expected to be the key drivers of growth in the sucralose market[1][5].

What are some of the major players in the sucralose market?

Major players include Tate and Lyle, JK Sucralose Inc., LAndP Food Ingredient Co. Ltd., Newtrend Group, BioPlus Life Sciences, and Ingredion Incorporated[1][2].

Sources

  1. Globenewswire: Sucralose Market to Reach USD 6.25 Billion by 2033; Emergence of Functional and Fortified Foods to Propel Growth.
  2. BCC Research: Sucralose Global Market Report 2023.
  3. Sigma-Aldrich: So much better than bitter - Sucralose.
  4. HKEXnews: INDUSTRY OVERVIEW.
  5. StraitsResearch: Global Sugar Based Excipients Market Size, Top share, Report to 2028.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.